AI and radiologist analysis of prostate MRI scans
Part of Cancer clinical trials.
This study compares how artificial intelligence and doctors interpret prostate MRI scans to improve cancer detection and guide treatment decisions. You'll have an MRI scan and possibly a biopsy to help researchers understand which approach works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older with concerns about prostate cancer
- Your PSA blood test is 20 ng/mL or lower
- You have never had a prostate biopsy before
- You have never had a prostate MRI scan before
- You can safely have an MRI (no pacemaker, metal implants, or severe claustrophobia)
- You are able to provide written consent and complete all study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This trial studies how AI might improve the process of prostate biopsies for people who have had an MRI. It may help if you are scheduled for a biopsy and have not been treated for prostate cancer before.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Hear when a new Prostate CA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.